Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent
Authors
Keywords
Low Grade Glioma, Ganglioglioma, MAP Kinase pathway, BRAF V600E, Vemurafenib
Journal
Journal of Translational Medicine
Volume 12, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-12-19
DOI
10.1186/s12967-014-0356-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
- (2014) Giles W Robinson et al. BMC CANCER
- Vemurafenib-Induced Neutrophilic Panniculitis in a Child with a Brainstem Glioma
- (2014) Emily S. West et al. PEDIATRIC DERMATOLOGY
- Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells
- (2013) Christian Koelsche et al. ACTA NEUROPATHOLOGICA
- BRAFV600E mutation is a negative prognosticator in pediatric ganglioglioma
- (2013) Sonika Dahiya et al. ACTA NEUROPATHOLOGICA
- Dysembryoplastic Neuroepithelial Tumors Share with Pleomorphic Xanthoastrocytomas and Gangliogliomas BRAFV600EMutation and Expression
- (2013) Céline Chappé et al. BRAIN PATHOLOGY
- Pediatric Brainstem Gangliogliomas ShowBRAFV600EMutation in a High Percentage of Cases
- (2013) Andrew M. Donson et al. BRAIN PATHOLOGY
- Long-term outcome of centrally located low-grade glioma in children
- (2013) Keita Terashima et al. CANCER
- Brainstem Ganglioglioma Successfully Treated With Vemurafenib
- (2013) Sarah Rush et al. JOURNAL OF CLINICAL ONCOLOGY
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
- (2013) NATURE GENETICS
- A multi-disciplinary consensus statement concerning surgical approaches to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method
- (2013) D. A. Walker et al. NEURO-ONCOLOGY
- Vemurafenib in pediatric patients withBRAFV600Emutated high-grade gliomas
- (2013) Francisco Bautista et al. PEDIATRIC BLOOD & CANCER
- The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
- (2013) E. M. Van Allen et al. Cancer Discovery
- Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group
- (2012) Joann L. Ater et al. JOURNAL OF CLINICAL ONCOLOGY
- The molecular biology of WHO grade I astrocytomas
- (2012) N. F. Marko et al. NEURO-ONCOLOGY
- Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas
- (2012) C. Horbinski et al. NEURO-ONCOLOGY
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncogenic FAM131B–BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma
- (2011) Huriye Cin et al. ACTA NEUROPATHOLOGICA
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
- (2011) Genevieve Schindler et al. ACTA NEUROPATHOLOGICA
- BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma
- (2011) C. Hawkins et al. CLINICAL CANCER RESEARCH
- Targeted Therapy for BRAFV600E Malignant Astrocytoma
- (2011) T. P. Nicolaides et al. CLINICAL CANCER RESEARCH
- BRAFAlterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549
- (2011) Alex Lin et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
- (2011) Poulikos I. Poulikakos et al. NATURE
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- Radiation Therapy for Pediatric Low-Grade Gliomas: Survival and Sequelae
- (2010) Roger J. Packer Current Neurology and Neuroscience Reports
- MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential
- (2010) Judith WM Jeuken et al. JOURNAL OF PATHOLOGY
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Duplication of 7q34 in Pediatric Low-Grade Astrocytomas Detected by High-Density Single-Nucleotide Polymorphism-Based Genotype Arrays Results in a NovelBRAFFusion Gene
- (2009) Angela J. Sievert et al. BRAIN PATHOLOGY
- Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours
- (2009) K Jacob et al. BRITISH JOURNAL OF CANCER
- Late Effects of Conformal Radiation Therapy for Pediatric Patients With Low-Grade Glioma: Prospective Evaluation of Cognitive, Endocrine, and Hearing Deficits
- (2009) Thomas E. Merchant et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Conformal Radiation Therapy for Pediatric Low-Grade Glioma
- (2009) Thomas E. Merchant et al. JOURNAL OF CLINICAL ONCOLOGY
- MEK1 mutations confer resistance to MEK and B-RAF inhibition
- (2009) C. M. Emery et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tandem Duplication Producing a Novel OncogenicBRAFFusion Gene Defines the Majority of Pilocytic Astrocytomas
- (2008) David T.W. Jones et al. CANCER RESEARCH
- BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
- (2008) Stefan Pfister et al. JOURNAL OF CLINICAL INVESTIGATION
- Frequent Gains at Chromosome 7q34 Involving BRAF in Pilocytic Astrocytoma
- (2008) Eli E. Bar et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas
- (2008) H Deshmukh et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now